Pharming: promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Berlin [u.a.]
Springer
2008
|
Schriftenreihe: | Ethics of Science and Technology Assessment
35 |
Schlagworte: | |
Beschreibung: | 332 S. 235 mm x 155 mm |
ISBN: | 9783540857921 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV035243463 | ||
003 | DE-604 | ||
005 | 20120314 | ||
007 | t | ||
008 | 090113s2008 gw |||| 00||| eng d | ||
015 | |a 08,N33,0494 |2 dnb | ||
016 | 7 | |a 989738094 |2 DE-101 | |
020 | |a 9783540857921 |c Gb. : ca. EUR 53.45 (freier Pr.), ca. sfr 83.00 (freier Pr.) |9 978-3-540-85792-1 | ||
024 | 3 | |a 9783540857921 | |
028 | 5 | 2 | |a 12451876 |
035 | |a (OCoLC)643750342 | ||
035 | |a (DE-599)DNB989738094 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE-BE | ||
049 | |a DE-12 | ||
082 | 0 | |a 615.19 |2 22/ger | |
084 | |a PJ 2880 |0 (DE-625)136694: |2 rvk | ||
084 | |a VS 5360 |0 (DE-625)147688:253 |2 rvk | ||
084 | |a WG 3450 |0 (DE-625)148549: |2 rvk | ||
084 | |a 610 |2 sdnb | ||
100 | 1 | |a Rehbinder, Eckard |d 1936- |e Verfasser |0 (DE-588)107044676 |4 aut | |
245 | 1 | 0 | |a Pharming |b promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals |c E. Rehbinder ... |
264 | 1 | |a Berlin [u.a.] |b Springer |c 2008 | |
300 | |a 332 S. |c 235 mm x 155 mm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Ethics of Science and Technology Assessment |v 35 | |
650 | 0 | 7 | |a Risikoanalyse |0 (DE-588)4137042-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Biotechnologie |0 (DE-588)4069491-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Transgener Organismus |0 (DE-588)4314075-0 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Transgener Organismus |0 (DE-588)4314075-0 |D s |
689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 0 | 2 | |a Risikoanalyse |0 (DE-588)4137042-9 |D s |
689 | 0 | 3 | |a Biotechnologie |0 (DE-588)4069491-4 |D s |
689 | 0 | |5 DE-604 | |
830 | 0 | |a Ethics of Science and Technology Assessment |v 35 |w (DE-604)BV039957297 |9 35 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-017049215 |
Datensatz im Suchindex
_version_ | 1804138517064843264 |
---|---|
any_adam_object | |
author | Rehbinder, Eckard 1936- |
author_GND | (DE-588)107044676 |
author_facet | Rehbinder, Eckard 1936- |
author_role | aut |
author_sort | Rehbinder, Eckard 1936- |
author_variant | e r er |
building | Verbundindex |
bvnumber | BV035243463 |
classification_rvk | PJ 2880 VS 5360 WG 3450 |
ctrlnum | (OCoLC)643750342 (DE-599)DNB989738094 |
dewey-full | 615.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.19 |
dewey-search | 615.19 |
dewey-sort | 3615.19 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie / Pharmazie Rechtswissenschaft Biologie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01872nam a2200505 cb4500</leader><controlfield tag="001">BV035243463</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20120314 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">090113s2008 gw |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">08,N33,0494</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">989738094</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783540857921</subfield><subfield code="c">Gb. : ca. EUR 53.45 (freier Pr.), ca. sfr 83.00 (freier Pr.)</subfield><subfield code="9">978-3-540-85792-1</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783540857921</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">12451876</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)643750342</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB989738094</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.19</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PJ 2880</subfield><subfield code="0">(DE-625)136694:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5360</subfield><subfield code="0">(DE-625)147688:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WG 3450</subfield><subfield code="0">(DE-625)148549:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Rehbinder, Eckard</subfield><subfield code="d">1936-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)107044676</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharming</subfield><subfield code="b">promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals</subfield><subfield code="c">E. Rehbinder ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">332 S.</subfield><subfield code="c">235 mm x 155 mm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Ethics of Science and Technology Assessment</subfield><subfield code="v">35</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Risikoanalyse</subfield><subfield code="0">(DE-588)4137042-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Transgener Organismus</subfield><subfield code="0">(DE-588)4314075-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Transgener Organismus</subfield><subfield code="0">(DE-588)4314075-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Risikoanalyse</subfield><subfield code="0">(DE-588)4137042-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Ethics of Science and Technology Assessment</subfield><subfield code="v">35</subfield><subfield code="w">(DE-604)BV039957297</subfield><subfield code="9">35</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-017049215</subfield></datafield></record></collection> |
id | DE-604.BV035243463 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T21:29:26Z |
institution | BVB |
isbn | 9783540857921 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-017049215 |
oclc_num | 643750342 |
open_access_boolean | |
owner | DE-12 |
owner_facet | DE-12 |
physical | 332 S. 235 mm x 155 mm |
publishDate | 2008 |
publishDateSearch | 2008 |
publishDateSort | 2008 |
publisher | Springer |
record_format | marc |
series | Ethics of Science and Technology Assessment |
series2 | Ethics of Science and Technology Assessment |
spelling | Rehbinder, Eckard 1936- Verfasser (DE-588)107044676 aut Pharming promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals E. Rehbinder ... Berlin [u.a.] Springer 2008 332 S. 235 mm x 155 mm txt rdacontent n rdamedia nc rdacarrier Ethics of Science and Technology Assessment 35 Risikoanalyse (DE-588)4137042-9 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Biotechnologie (DE-588)4069491-4 gnd rswk-swf Transgener Organismus (DE-588)4314075-0 gnd rswk-swf Transgener Organismus (DE-588)4314075-0 s Arzneimittel (DE-588)4003115-9 s Risikoanalyse (DE-588)4137042-9 s Biotechnologie (DE-588)4069491-4 s DE-604 Ethics of Science and Technology Assessment 35 (DE-604)BV039957297 35 |
spellingShingle | Rehbinder, Eckard 1936- Pharming promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals Ethics of Science and Technology Assessment Risikoanalyse (DE-588)4137042-9 gnd Arzneimittel (DE-588)4003115-9 gnd Biotechnologie (DE-588)4069491-4 gnd Transgener Organismus (DE-588)4314075-0 gnd |
subject_GND | (DE-588)4137042-9 (DE-588)4003115-9 (DE-588)4069491-4 (DE-588)4314075-0 |
title | Pharming promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals |
title_auth | Pharming promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals |
title_exact_search | Pharming promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals |
title_full | Pharming promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals E. Rehbinder ... |
title_fullStr | Pharming promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals E. Rehbinder ... |
title_full_unstemmed | Pharming promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals E. Rehbinder ... |
title_short | Pharming |
title_sort | pharming promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals |
title_sub | promises and risks of biopharmaceuticals derived fromgenetically modified plants and animals |
topic | Risikoanalyse (DE-588)4137042-9 gnd Arzneimittel (DE-588)4003115-9 gnd Biotechnologie (DE-588)4069491-4 gnd Transgener Organismus (DE-588)4314075-0 gnd |
topic_facet | Risikoanalyse Arzneimittel Biotechnologie Transgener Organismus |
volume_link | (DE-604)BV039957297 |
work_keys_str_mv | AT rehbindereckard pharmingpromisesandrisksofbiopharmaceuticalsderivedfromgeneticallymodifiedplantsandanimals |